TNFSF10 and cancer: Frequent in vivo reports have shown that a diversity of cytokines, ranging from interleukins (ILs) to interferons (IFNs), and also tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), have unique antitumor competencies, highlighting the importance of their application for cancer therapy (12–14).